Logo
x

Search

Subscribe Now

Zejula

GSK's Zejula (niraparib) Receives EC's Approval as a Treatment in Advanced Ovarian Cancer

GSK's Zejula (niraparib) Receives EC's Approval as a Treatment in Advanced Ovarian Cancer

  • October 30, 2020
GSK's Zejula (niraparib) Receives Health Canada Approval for 1L Treatment of Women with Advanced Ovarian Cancer

GSK's Zejula (niraparib) Receives Health Canada Approval for 1L Treatment of Women with Advanced Ovarian Cancer

  • October 6, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.